| Genomic epidemiology of the Mycobacterium tuberculosis complex in Fiji reveals community transmission and human Mycobacterium bovis infection.
doi:10.3389/fmicb.2026.1933597
|
Front Microbiol |
2026 |
| Comparative whole genome analysis of Mycobacterium tuberculosis isolated from BPaLM and individualized regimen treated patients at Dr. Soetomo Hospital, Indonesia.
doi:10.1007/s11033-026-12652-7
|
Mol Biol Rep |
2026 |
| Molecular Mechanisms Underlying Antimicrobial Resistance in Mycobacteria.
doi:10.3390/ijms27156893
|
Int J Mol Sci |
2026 |
| Whole-genome sequencing reveals lineage-associated drug resistance and enables machine learning-based prediction in Mycobacterium tuberculosis clinical isolates.
doi:10.3389/fmicb.2026.1828991
|
Front Microbiol |
2026 |
| Kinetical Analysis of Mutant PZase Enzyme To Uncover The Pyrazinamide Resistance In Mycobacterium tuberculosis Clinical Isolates.
|
New Microbiol |
2026 |
| Toward precision detection of pyrazinamide resistance: critical concentration assessment and rapid molecular method validation.
doi:10.3389/fmicb.2026.1828630
|
Front Microbiol |
2026 |
| Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: impact of false-positive BD MGIT 960 results and added value of sequencing for accurate diagnosis in a low-MDR-TB-incidence context.
doi:10.3389/fcimb.2026.1777714
|
Front Cell Infect Microbiol |
2026 |
| Genetic Characterization of First-Line Drug-Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis.
doi:10.3390/pathogens15050455
|
Pathogens |
2026 |
| Effects of mutations conferring pyrazinamide resistance among multidrug-resistant tuberculosis isolates from China.
doi:10.1128/spectrum.00641-26
|
Microbiol Spectr |
2026 |
| Evaluation of DNA extraction methods from clinical Mycobacterium tuberculosis primary liquid culture for whole-genome sequencing.
doi:10.1186/s12864-026-12812-w
|
BMC Genomics |
2026 |
| Association of pyrazinamide resistance in Mycobacterium tuberculosis with mutations in rpoB, katG, and inhA genes.
doi:10.1038/s41598-026-53296-8
|
Sci Rep |
2026 |
| First-line drug-resistant tuberculosis among children under 15 years in Ethiopia: insights from phenotypic and whole-genome sequencing approaches.
doi:10.1186/s12879-026-13206-9
|
BMC Infect Dis |
2026 |
| Comparative transcriptomic profiling of pyrazinamide resistance in Mycobacterium tuberculosis.
doi:10.1093/jambio/lxag064
|
J Appl Microbiol |
2026 |
| Predicting pyrazinamide resistance in Mycobacterium tuberculosis using a graph convolutional network.
doi:10.1186/s12866-026-04876-1
|
BMC Microbiol |
2026 |
| Genetic and immunologic determinants of BCG disease: from mechanism to prevention.
doi:10.1080/07853890.2026.2634548
|
Ann Med |
2026 |
| Association between overexpression of efflux pumps genes Rv0191 and Rv3008 and pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis: a multi-center study.
doi:10.1186/s12879-026-12793-x
|
BMC Infect Dis |
2026 |
| Targeting Mycobacterium tuberculosis: The Role of Alkyl Substitution in Pyrazinamide Derivatives.
doi:10.1021/acsomega.5c07249
|
ACS Omega |
2026 |
| Characterization of pulmonary tuberculosis in high-altitude region using nanopore targeted sequencing.
doi:10.1186/s12866-026-04761-x
|
BMC Microbiol |
2026 |
| Whole Genome Sequencing Analysis Revealed High Genetic Diversity and Drug-Resistant Characteristics of Mycobacterium bovis From Chinese Farms.
doi:10.1111/zph.70026
|
Zoonoses Public Health |
2026 |
| Machine learning approaches to predict drug resistance in tuberculosis.
doi:10.1016/j.compbiolchem.2025.108705
|
Comput Biol Chem |
2026 |
| Drug resistance profile of Mycobacterium tuberculosis in China: update until 2024.
doi:10.3389/fmicb.2025.1697490
|
Front Microbiol |
2025 |
| Molecular Epidemiology of Mycobacterium tuberculosis in Mexico.
doi:10.3390/microorganisms13112453
|
Microorganisms |
2025 |
| Genomic characterization of XDR Mycobacterium tuberculosis isolates in Argentina (2006-2015).
doi:10.1186/s12879-025-11913-3
|
BMC Infect Dis |
2025 |
| Characterization of Drug Resistance Mutations in Mycobacterium tuberculosis Isolates from Moroccan Patients Using Deeplex Targeted Next-Generation Sequencing.
doi:10.3390/microorganisms13092163
|
Microorganisms |
2025 |
| Genomic insights into pyrazinamide and fluoroquinolone resistance in multidrug-resistant tuberculosis in Khyber Pakhtunkhwa, Pakistan.
doi:10.1016/j.ijmm.2025.151674
|
Int J Med Microbiol |
2025 |
| Enhancing diagnostic efficiency of pyrazinamide resistance in Mycobacterium tuberculosis via modified MGIT assay and genotypic correlation.
doi:10.1016/j.crmicr.2025.100462
|
Curr Res Microb Sci |
2025 |
| S292L mutation in Rv1258c efflux pump drives pyrazinamide efflux and a novel inhibitor designed for co-therapy to improve MDR-TB treatment outcomes.
doi:10.1007/s11274-025-04510-8
|
World J Microbiol Biotechnol |
2025 |
| Whole-genome sequencing for analyzing the transmission characteristics of drug-resistant Mycobacterium tuberculosis in Ganzhou, China.
doi:10.1186/s12879-025-11356-w
|
BMC Infect Dis |
2025 |
| Lineage identification and mutation profile of Mycobacterium tuberculosis: A study from National Reference Laboratory, India.
doi:10.1016/j.ijmmb.2025.100925
|
Indian J Med Microbiol |
2025 |
| The Identification of Novel Mutations in ATP-Dependent Protease ClpC1 Assists in the Molecular Diagnosis of Obscured Pyrazinamide-Resistant Tuberculosis Clinical Isolates.
doi:10.3390/microorganisms13061401
|
Microorganisms |
2025 |
| Evolutionary Genetic Analysis of the Pyrazinamidase Gene in Seven Global Populations of Mycobacterium tuberculosis.
doi:10.4103/ijmy.ijmy_30_25
|
Int J Mycobacteriol |
2025 |
| Investigation of potential relationship betweenmazEF3, relJK, and vapBC3 genes and antimicrobial resistance inMycobacterium bovis.
doi:10.1186/s12879-025-11168-y
|
BMC Infect Dis |
2025 |
| Comprehensive evaluation of the MeltPro MTB/PZA assay for prediction of pyrazinamide resistance in multidrug-resistant tuberculosis.
doi:10.1128/spectrum.02745-24
|
Microbiol Spectr |
2025 |
| Whole-genome sequencing analysis to identify antimicrobial resistance regions and virulence factors in Mycobacterium tuberculosis isolates from the Amhara Region, Ethiopia.
doi:10.1038/s41598-025-01241-6
|
Sci Rep |
2025 |
| Tuberculosis in Malaysia: Disease timeline, epidemiology, control initiatives and outlook.
|
Malays J Pathol |
2025 |
| Prevalence and Clinical Implications of Pyrazinamide Resistance in Newly Diagnosed TB Patients in Uganda.
doi:10.2147/IDR.S491770
|
Infect Drug Resist |
2025 |
| Whole genomic analysis uncovers high genetic diversity of rifampicin-resistant Mycobacterium tuberculosis strains in Botswana.
doi:10.3389/fmicb.2025.1535160
|
Front Microbiol |
2025 |
| Genetic diversity and transmission pattern of multidrug-resistant tuberculosis based on whole-genome sequencing in Wuhan, China.
doi:10.3389/fpubh.2025.1442987
|
Front Public Health |
2025 |
| The epidemiology and gene mutation characteristics of pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates in Southern China.
doi:10.1080/22221751.2024.2447607
|
Emerg Microbes Infect |
2025 |
| Phylogenetically Informative Mutations in Drug Resistance Genes of Human-Infecting Mycobacterium bovis.
doi:10.1155/2024/5578214
|
Transbound Emerg Dis |
2024 |
| Phenotypic and genotypic characterization of Mycobacterium tuberculosis pyrazinamide resistance-India, 2018-2020.
doi:10.3389/fmicb.2024.1515627
|
Front Microbiol |
2024 |
| A simplified pyrazinamidase test for Mycobacterium tuberculosis pyrazinamide antimicrobial susceptibility testing.
doi:10.1128/jcm.01227-24
|
J Clin Microbiol |
2024 |
| Analysis of genetic characteristics associated with reduced bedaquiline susceptibility in multidrug-resistant Mycobacterium tuberculosis.
doi:10.1016/j.tube.2024.102572
|
Tuberculosis (Edinb) |
2024 |
| Mycobacterium tuberculosis evolution from monoresistance to pre-extensive drug resistance during a prolonged household outbreak.
doi:10.1016/j.jctube.2024.100482
|
J Clin Tuberc Other Mycobact Dis |
2024 |
| Genetic diversities and drug resistance in Mycobacterium bovis isolates from zoonotic tuberculosis using whole genome sequencing.
doi:10.1186/s12864-024-10909-8
|
BMC Genomics |
2024 |
| Genome sequencing analysis of the pncA, rpsA and panD genes responsible for pyrazinamide resistance of Mycobacterium tuberculosis from Indonesian isolates.
doi:10.1111/tmi.14051
names it
|
Trop Med Int Health |
2024 |
| Pyrazinamide resistance due to pncA gene mutation and its association with treatment outcome among tuberculosis patients of South India- A longitudinal observational study.
doi:10.1016/j.ijtb.2024.03.006
names it
|
Indian J Tuberc |
2024 |
| Biphasic Medium Using Nicotinamide for Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis.
doi:10.3390/antibiotics13060563
|
Antibiotics (Basel) |
2024 |
| Drug Susceptibility and Mutation Profiles in Mycobacterium tuberculosis Isolates from a Tertiary Care Hospital in Kerala, India.
doi:10.4269/ajtmh.24-0042
|
Am J Trop Med Hyg |
2024 |
| Identification of positively selected genes in Mycobacterium tuberculosis from southern Xinjiang Uygur autonomous region of China.
doi:10.3389/fmicb.2024.1290227
|
Front Microbiol |
2024 |
| Mechanistic insights into the conformational changes and alterations in residual communications due to the mutations in the pncA Gene of Mycobacterium tuberculosis: A computational perspective for effective therapeutic solutions.
doi:10.1016/j.compbiolchem.2024.108065
names it
|
Comput Biol Chem |
2024 |
| Comparison of targeted next-generation sequencing and the Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis in clinical isolates and sputum specimens.
doi:10.1128/spectrum.04098-23
|
Microbiol Spectr |
2024 |
| Concordance of targeted and whole genome sequencing for Mycobacterium tuberculosis genotypic drug susceptibility testing.
doi:10.1016/j.diagmicrobio.2024.116249
|
Diagn Microbiol Infect Dis |
2024 |
| Prediction of pyrazinamide resistance in Mycobacterium tuberculosis using structure-based machine-learning approaches.
doi:10.1093/jacamr/dlae037
|
JAC Antimicrob Resist |
2024 |
| Rapid detection of multidrug resistance in tuberculosis using nanopore-based targeted next-generation sequencing: a multicenter, double-blind study.
doi:10.3389/fmicb.2024.1349715
|
Front Microbiol |
2024 |
| Exploring of pyrazinamidase recombinant activity from PZA-sensitive and resistant Mycobacterium tuberculosis expressed in Escherichia coli BL21 (DE3).
doi:10.1590/1519-6984.278911
|
Braz J Biol |
2024 |
| Prevalence, Transmission and Genetic Diversity of Pyrazinamide Resistance Among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Hunan, China.
doi:10.2147/IDR.S436161
|
Infect Drug Resist |
2024 |
| Emerging insight of whole genome sequencing coupled with protein structure prediction into the pyrazinamide-resistance signature of Mycobacterium tuberculosis.
doi:10.1016/j.ijantimicag.2023.107053
|
Int J Antimicrob Agents |
2024 |
| Free energy landscape and thermodynamics properties of novel mutations in PncA of pyrazinamide resistance isolates of Mycobacterium tuberculosis.
doi:10.1080/07391102.2023.2268216
names it
|
J Biomol Struct Dyn |
2024 |
| Insights from the molecular mechanism of pyrazinamide to mutated pyrazinamidase linked to the pncA gene in clinical isolates of Mycobacterium tuberculosis.
doi:10.1080/07391102.2023.2195002
names it
|
J Biomol Struct Dyn |
2024 |
| A precision overview of genomic resistance screening in Ecuadorian isolates of Mycobacterium tuberculosis using web-based bioinformatics tools.
doi:10.1371/journal.pone.0294670
|
PLoS One |
2023 |
| Antimicrobial drug resistant features of Mycobacterium tuberculosis associated with treatment failure.
doi:10.1371/journal.pone.0293194
|
PLoS One |
2023 |
| Genetic surveillance and outcomes of pyrazinamide and fluoroquinolones-resistant tuberculosis in Taiwan.
doi:10.1016/j.jmii.2023.08.013
|
J Microbiol Immunol Infect |
2023 |
| Whole genome sequencing of drug resistance Mycobacterium tuberculosis from extra-pulmonary sites.
doi:10.26508/lsa.202302076
|
Life Sci Alliance |
2023 |
| Pharmacokinetic Considerations for Optimizing Inhaled Spray-Dried Pyrazinoic Acid Formulations.
doi:10.1021/acs.molpharmaceut.3c00199
|
Mol Pharm |
2023 |
| Surveillance of multidrug-resistant tuberculosis in sub-Saharan Africa through wastewater-based epidemiology.
doi:10.1016/j.heliyon.2023.e18302
|
Heliyon |
2023 |
| Drug resistance prediction for Mycobacterium tuberculosis with reference graphs.
doi:10.1099/mgen.0.001081
|
Microb Genom |
2023 |
| Deciphering the emerging role of phytocompounds: Implications in the management of drug-resistant tuberculosis and ATDs-induced hepatic damage.
doi:10.1016/j.jiph.2023.07.016
|
J Infect Public Health |
2023 |
| pncA Large Deletion is the Characteristic of Pyrazinamide-Resistant Mycobacterium tuberculosis belonging to the East Asian Lineage.
doi:10.3947/ic.2023.0037
names it
|
Infect Chemother |
2023 |
| Emergence and evolution of drug-resistant Mycobacterium tuberculosis in eastern China: A six-year prospective study.
doi:10.1016/j.ygeno.2023.110640
|
Genomics |
2023 |
| Quantitative (1)H Nuclear Magnetic Resonance Assay for the Rapid Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis from Sputum Samples.
doi:10.1128/jcm.01522-22
|
J Clin Microbiol |
2023 |
| Pharmacokinetic considerations for optimizing inhaled spray-dried pyrazinoic acid formulations.
doi:10.1101/2023.04.01.534965
|
bioRxiv |
2023 |
| Pyrazinamide-resistant Tuberculosis Obscured From Common Targeted Molecular Diagnostics.
doi:10.1016/j.drup.2023.100959
|
Drug Resist Updat |
2023 |
| Online Service with Automated Interpretation of Sequencing Data and Prediction of Pyrazinamide Resistance in Mycobacterium tuberculosis.
doi:10.1007/s10517-023-05758-6
|
Bull Exp Biol Med |
2023 |
| Bacterial PncA improves diet-induced NAFLD in mice by enabling the transition from nicotinamide to nicotinic acid.
doi:10.1038/s42003-023-04613-8
names it
|
Commun Biol |
2023 |
| Deciphering the mechanism of resistance by novel double mutations in pncA in Mycobacterium tuberculosis using protein structural graphs (PSG) and structural bioinformatic approaches.
doi:10.1016/j.compbiomed.2023.106599
names it
|
Comput Biol Med |
2023 |
| The past, present and future of tuberculosis treatment.
doi:10.3724/zdxbyxb-2022-0454
|
Zhejiang Da Xue Xue Bao Yi Xue Ban |
2022 |
| Comparative genome analysis reveals high-level drug resistance markers in a clinical isolate of Mycobacterium fortuitum subsp. fortuitum MF GZ001.
doi:10.3389/fcimb.2022.1056007
|
Front Cell Infect Microbiol |
2022 |
| Genomic analysis of Mycobacterium tuberculosis variant bovis strains isolated from bovine in the state of Mato Grosso, Brazil.
doi:10.3389/fvets.2022.1006090
|
Front Vet Sci |
2022 |
| Structure activity relationship of pyrazinoic acid analogs as potential antimycobacterial agents.
doi:10.1016/j.bmc.2022.117046
|
Bioorg Med Chem |
2022 |
| Mutations Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis: A Review and Update.
doi:10.1007/s00284-022-03032-y
|
Curr Microbiol |
2022 |
| Detection of Mutations in pncA in Mycobacterium tuberculosis Clinical Isolates from Nepal in Association with Pyrazinamide Resistance.
doi:10.3390/cimb44090283
names it
|
Curr Issues Mol Biol |
2022 |
| Pyrazinamide resistance in rifampicin discordant tuberculosis.
doi:10.1371/journal.pone.0274688
|
PLoS One |
2022 |
| Pyrazinamide Resistance and pncA Mutation Profiles in Multidrug Resistant Mycobacterium Tuberculosis.
doi:10.2147/IDR.S368444
names it
|
Infect Drug Resist |
2022 |
| Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
doi:10.1371/journal.pone.0271508
|
PLoS One |
2022 |
| Drug resistant Mycobacterium tuberculosis in Oman: resistance-conferring mutations and lineage diversity.
doi:10.7717/peerj.13645
|
PeerJ |
2022 |
| [Prevalence and transmission of pyrazinamide-resistant Mycobacterium tuberculosis in Hunan Province,China].
doi:10.3760/cma.j.cn112147-20211219-00904
|
Zhonghua Jie He He Hu Xi Za Zhi |
2022 |
| Intra-host genetic population diversity: Role in emergence and persistence of drug resistance among Mycobacterium tuberculosis complex minor variants.
doi:10.1016/j.meegid.2022.105288
|
Infect Genet Evol |
2022 |
| [Investigation of pncA, rpsA and panD Gene Mutations Associated with Resistance in Pyrazinamide-Resistant Mycobacterium tuberculosis Isolates and Spoligotyping].
doi:10.5578/mb.20229801
names it
|
Mikrobiyol Bul |
2022 |
| Identification of mutations in rpoB, pncA, embB, and ubiA genes among drug-resistant Mycobacterium tuberculosis clinical isolates from Iran.
doi:10.1556/030.2022.01730
names it
|
Acta Microbiol Immunol Hung |
2022 |
| Characterization of Fluoroquinolone-Resistant and Multidrug-Resistant Mycobacterium tuberculosis Isolates Using Whole-Genome Sequencing in Tianjin, China.
doi:10.2147/IDR.S361635
|
Infect Drug Resist |
2022 |
| Structural and Dynamic Insights into the W68L, L85P, and T87A Mutations of Mycobacterium tuberculosis Inducing Resistance to Pyrazinamide.
doi:10.3390/ijerph19031615
|
Int J Environ Res Public Health |
2022 |
| Next-generation sequencing to characterise pyrazinamide resistance in Mycobacterium tuberculosis isolates from two Balkan countries.
doi:10.1016/j.jgar.2021.09.019
|
J Glob Antimicrob Resist |
2022 |
| Comparative Performance of Genomic Methods for the Detection of Pyrazinamide Resistance and Heteroresistance in Mycobacterium tuberculosis.
doi:10.1128/JCM.01907-21
|
J Clin Microbiol |
2022 |
| The pncA gene mutations of Mycobacterium tuberculosis in multidrug-resistant tuberculosis.
doi:10.1002/bab.2278
names it
|
Biotechnol Appl Biochem |
2022 |
| Evaluation of PCR pncA-restriction fragment length polymorphism and PCR amplification of genomic regions of difference for the identification of M. bovis strains in lymph nodes cultures.
doi:10.4314/ahs.v21i3.4
names it
|
Afr Health Sci |
2021 |
| Prevalences of levofloxacin resistance and pncA mutation in isoniazid-resistant Mycobacterium tuberculosis in Hong Kong.
doi:10.12809/hkmj208553
names it
|
Hong Kong Med J |
2021 |
| Whole Genome Sequencing of Drug Resistant and Drug Susceptible Mycobacterium tuberculosis Isolates From Tigray Region, Ethiopia.
doi:10.3389/fmicb.2021.743198
|
Front Microbiol |
2021 |
| Whole genome sequencing reveals large deletions and other loss of function mutations in Mycobacterium tuberculosis drug resistance genes.
doi:10.1099/mgen.0.000724
|
Microb Genom |
2021 |
| Wastewater-Based Surveillance of Antibiotic Resistance Genes Associated with Tuberculosis Treatment Regimen in KwaZulu Natal, South Africa.
doi:10.3390/antibiotics10111362
|
Antibiotics (Basel) |
2021 |
| The whole-genome sequencing in predicting Mycobacterium tuberculosis drug susceptibility and resistance in Papua, Indonesia.
doi:10.1186/s12864-021-08139-3
|
BMC Genomics |
2021 |
| Genetic Diversity and Drug Susceptibility Profiles of Multidrug-Resistant Tuberculosis Strains in Southeast China.
doi:10.2147/IDR.S331516
|
Infect Drug Resist |
2021 |
| Structural and Genomic Insights Into Pyrazinamide Resistance in Mycobacterium tuberculosis Underlie Differences Between Ancient and Modern Lineages.
doi:10.3389/fmolb.2021.619403
|
Front Mol Biosci |
2021 |
| Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China.
doi:10.1186/s12879-021-06306-1
|
BMC Infect Dis |
2021 |
| Insights Into Mutations Induced Conformational Changes and Rearrangement of Fe(2+) Ion in pncA Gene of Mycobacterium tuberculosis to Decipher the Mechanism of Resistance to Pyrazinamide.
doi:10.3389/fmolb.2021.633365
names it
|
Front Mol Biosci |
2021 |
| The 7H11 Agar Medium Supplemented with Calf Bovine Serum for Susceptibility Testing of Mycobacterium tuberculosis Isolates Against Pyrazinamide.
doi:10.1089/mdr.2020.0509
|
Microb Drug Resist |
2021 |
| Computational modeling and bioinformatic analyses of functional mutations in drug target genes in Mycobacterium tuberculosis.
doi:10.1016/j.csbj.2021.04.034
|
Comput Struct Biotechnol J |
2021 |
| Overcoming the Challenges of Pyrazinamide Susceptibility Testing in Clinical Mycobacterium tuberculosis Isolates.
doi:10.1128/AAC.02617-20
|
Antimicrob Agents Chemother |
2021 |
| Molecular epidemiology of Mycobacterium tuberculosis in adult Filipino TB-HIV co-infected patients.
doi:10.5588/ijtld.20.0878
|
Int J Tuberc Lung Dis |
2021 |
| Value of routine whole genome sequencing for Mycobacterium tuberculosis drug resistance detection.
doi:10.1016/j.ijid.2021.03.033
|
Int J Infect Dis |
2021 |
| Genome analyses of 174 strains of Mycobacterium tuberculosis provide insight into the evolution of drug resistance and reveal potential drug targets.
doi:10.1099/mgen.0.000542
|
Microb Genom |
2021 |
| Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis.
doi:10.1128/AAC.01916-20
|
Antimicrob Agents Chemother |
2021 |
| Synthesis, in vitro antibacterial activity against Mycobacterium tuberculosis, and reverse docking-based target fishing of 1,4-benzoxazin-2-one derivatives.
doi:10.1002/ardp.202000199
|
Arch Pharm (Weinheim) |
2021 |
| Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: A subsequent study of a national survey.
doi:10.1016/j.jinf.2021.02.004
|
J Infect |
2021 |
| Drug resistance gene mutations and treatment outcomes in MDR-TB: A prospective study in Eastern China.
doi:10.1371/journal.pntd.0009068
|
PLoS Negl Trop Dis |
2021 |
| A computational perspective on the dynamic behaviour of recurrent drug resistance mutations in the pncA gene from Mycobacterium tuberculosis.
doi:10.1039/d0ra09326b
names it
|
RSC Adv |
2021 |
| An explainable machine learning platform for pyrazinamide resistance prediction and genetic feature identification of Mycobacterium tuberculosis.
doi:10.1093/jamia/ocaa233
|
J Am Med Inform Assoc |
2021 |
| Genotypic Resistance of Pyrazinamide but Not Minimum Inhibitory Concentration Is Associated With Longer Time to Sputum Culture Conversion in Patients With Multidrug-resistant Tuberculosis.
doi:10.1093/cid/ciaa1509
|
Clin Infect Dis |
2021 |
| The Prospective Synergy of Antitubercular Drugs With NAD Biosynthesis Inhibitors.
doi:10.3389/fmicb.2020.634640
|
Front Microbiol |
2020 |
| Characterization of pncA Mutations and Prediction of PZA Resistance in Mycobacterium tuberculosis Clinical Isolates From Chongqing, China.
doi:10.3389/fmicb.2020.594171
names it
|
Front Microbiol |
2020 |
| Pyrazinamide resistance and pncA mutations in drug resistant Mycobacterium tuberculosis clinical isolates from Myanmar.
doi:10.1016/j.tube.2020.102013
names it
|
Tuberculosis (Edinb) |
2020 |
| Mechanistic analysis of A46V, H57Y, and D129N in pyrazinamidase associated with pyrazinamide resistance.
doi:10.1016/j.sjbs.2020.07.015
|
Saudi J Biol Sci |
2020 |
| Pyrazinamide resistance of novel mutations in pncA and their dynamic behavior.
doi:10.1039/d0ra06072k
names it
|
RSC Adv |
2020 |
| Pyrazinamide Resistance and Mutation Patterns Among Multidrug-Resistant Mycobacterium tuberculosis from Henan Province.
doi:10.2147/IDR.S260161
|
Infect Drug Resist |
2020 |
| Colorimetric methods for rapid determination of pyrazinamide resistance.
doi:10.4103/ijmy.ijmy_42_20
|
Int J Mycobacteriol |
2020 |
| Prediction of Mycobacterium tuberculosis pyrazinamidase function based on structural stability, physicochemical and geometrical descriptors.
doi:10.1371/journal.pone.0235643
|
PLoS One |
2020 |
| Pentacyanoferrate(II) complex of pyridine-4- and pyrazine-2-hydroxamic acid as source of HNO: investigation of anti-tubercular and vasodilation activities.
doi:10.1007/s00775-020-01805-z
|
J Biol Inorg Chem |
2020 |
| How To Optimally Combine Genotypic and Phenotypic Drug Susceptibility Testing Methods for Pyrazinamide.
doi:10.1128/AAC.01003-20
|
Antimicrob Agents Chemother |
2020 |
| Determining the unbinding events and conserved motions associated with the pyrazinamide release due to resistance mutations of Mycobacterium tuberculosis pyrazinamidase.
doi:10.1016/j.csbj.2020.05.009
|
Comput Struct Biotechnol J |
2020 |
| Survey of drug resistance associated gene mutations in Mycobacterium tuberculosis, ESKAPE and other bacterial species.
doi:10.1038/s41598-020-65766-8
|
Sci Rep |
2020 |
| Genomic signatures of drug resistance in highly resistant Mycobacterium tuberculosis strains of the early ancient sublineage of Beijing genotype in Russia.
doi:10.1016/j.ijantimicag.2020.106036
|
Int J Antimicrob Agents |
2020 |
| [Analysis on drug resistance-associated mutations of multi-drug resistant Mycobacterium tuberculosis based on whole-genome sequencing in China].
doi:10.3760/cma.j.cn112338-20191111-00800
|
Zhonghua Liu Xing Bing Xue Za Zhi |
2020 |
| High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda.
doi:10.1371/journal.pone.0232543
names it
|
PLoS One |
2020 |
| Detection of drug resistant Mycobacterium tuberculosis by high-throughput sequencing of DNA isolated from acid fast bacilli smears.
doi:10.1371/journal.pone.0232343
|
PLoS One |
2020 |
| Gibbs Free Energy Calculation of Mutation in PncA and RpsA Associated With Pyrazinamide Resistance.
doi:10.3389/fmolb.2020.00052
names it
|
Front Mol Biosci |
2020 |
| Mycobacterium smegmatis msmeg_3314 is involved in pyrazinamide and fluoroquinolones susceptibility via NAD(+)/NADH dysregulation.
doi:10.2217/fmb-2019-0071
|
Future Microbiol |
2020 |
| Characterization of katG, inhA, rpoB and pncA in Mycobacterium tuberculosis isolates from MDR-TB risk patients in Thailand.
doi:10.3855/jidc.11974
names it
|
J Infect Dev Ctries |
2020 |
| Artificial Intelligence and Machine learning based prediction of resistant and susceptible mutations in Mycobacterium tuberculosis.
doi:10.1038/s41598-020-62368-2
|
Sci Rep |
2020 |
| Detection of Novel Gene Mutations Associated with Pyrazinamide Resistance in Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Southern China.
doi:10.2147/IDR.S230774
|
Infect Drug Resist |
2020 |
| Rapid Pyrazinamide Drug Susceptibility Testing using a Closed-Tube PCR Assay of the Entire pncA gene.
doi:10.1038/s41598-020-61286-7
names it
|
Sci Rep |
2020 |
| Direct Determination of Pyrazinamide (PZA) Susceptibility by Sputum Microscopic Observation Drug Susceptibility (MODS) Culture at Neutral pH: the MODS-PZA Assay.
doi:10.1128/JCM.01165-19
|
J Clin Microbiol |
2020 |
| Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievements.
doi:10.1016/j.rmed.2019.105844
|
Respir Med |
2020 |
| Structure guided prediction of Pyrazinamide resistance mutations in pncA.
doi:10.1038/s41598-020-58635-x
names it
|
Sci Rep |
2020 |
| Molecular identification of mutations conferring resistance to rifampin, isoniazid and pyrazinamide among Mycobacterium tuberculosis isolates from Iran.
doi:10.1080/1120009X.2020.1716479
|
J Chemother |
2020 |
| Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China.
doi:10.1186/s12879-020-4758-9
|
BMC Infect Dis |
2020 |
| Nicotinamide Limits Replication of Mycobacterium tuberculosis and Bacille Calmette-Guérin Within Macrophages.
doi:10.1093/infdis/jiz541
|
J Infect Dis |
2020 |
| Molecular investigation against the resistant mechanism of PncA mutated pyrazinamide resistance and insight into the role of pH environment for pyrazinamide activation.
doi:10.1080/07391102.2019.1659854
names it
|
J Biomol Struct Dyn |
2020 |
| Structural dynamics behind variants in pyrazinamidase and pyrazinamide resistance.
doi:10.1080/07391102.2019.1650113
|
J Biomol Struct Dyn |
2020 |
| Structural Dynamics Behind Clinical Mutants of PncA-Asp12Ala, Pro54Leu, and His57Pro of Mycobacterium tuberculosis Associated With Pyrazinamide Resistance.
doi:10.3389/fbioe.2019.00404
names it
|
Front Bioeng Biotechnol |
2019 |
| Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB.
doi:10.1186/s40001-019-0397-2
|
Eur J Med Res |
2019 |
| Detection of Mutations in Mycobacterium tuberculosis pncA Gene by Modified High-Resolution Melting Curve Analysis of PCR Products.
doi:10.1007/s10517-019-04688-6
names it
|
Bull Exp Biol Med |
2019 |
| Improved Resistance Prediction in Mycobacterium tuberculosis by Better Handling of Insertions and Deletions, Premature Stop Codons, and Filtering of Non-informative Sites.
doi:10.3389/fmicb.2019.02464
|
Front Microbiol |
2019 |
| Resistance To First-Line Antituberculosis Drugs And Prevalence Of pncA Mutations In Clinical Isolates Of Mycobacterium tuberculosis From Zunyi, Guizhou Province Of China.
doi:10.2147/IDR.S222943
names it
|
Infect Drug Resist |
2019 |
| Whole genome sequencing, analyses of drug resistance-conferring mutations, and correlation with transmission of Mycobacterium tuberculosis carrying katG-S315T in Hanoi, Vietnam.
doi:10.1038/s41598-019-51812-7
|
Sci Rep |
2019 |
| Antibiotic resistance of Mycobacterium tuberculosis complex in Africa: A systematic review of current reports of molecular epidemiology, mechanisms and diagnostics.
doi:10.1016/j.jinf.2019.10.006
|
J Infect |
2019 |
| Whole genome sequencing of drug resistant Mycobacterium tuberculosis isolates from a high burden tuberculosis region of North West Pakistan.
doi:10.1038/s41598-019-51562-6
|
Sci Rep |
2019 |
| Spoligotyping with pncA sequencing strategy conferring the transmission of multidrug-resistant tuberculosis in Egypt.
doi:10.4103/ijmy.ijmy_111_19
names it
|
Int J Mycobacteriol |
2019 |
| Retrospective Analysis of Archived Pyrazinamide Resistant Mycobacterium tuberculosis Complex Isolates from Uganda-Evidence of Interspecies Transmission.
doi:10.3390/microorganisms7080221
|
Microorganisms |
2019 |
| Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of pncA PCR Sequencing.
doi:10.1128/JCM.00145-19
names it
|
J Clin Microbiol |
2019 |
| WGS more accurately predicts susceptibility of Mycobacterium tuberculosis to first-line drugs than phenotypic testing.
doi:10.1093/jac/dkz215
|
J Antimicrob Chemother |
2019 |
| Structural and free energy landscape of novel mutations in ribosomal protein S1 (rpsA) associated with pyrazinamide resistance.
doi:10.1038/s41598-019-44013-9
|
Sci Rep |
2019 |
| Overcoming the pitfalls of automatic interpretation of whole genome sequencing data by online tools for the prediction of pyrazinamide resistance in Mycobacterium tuberculosis.
doi:10.1371/journal.pone.0212798
|
PLoS One |
2019 |
| Exploring the Pyrazinamide Drug Resistance Mechanism of Clinical Mutants T370P and W403G in Ribosomal Protein S1 of Mycobacterium tuberculosis.
doi:10.1021/acs.jcim.8b00956
|
J Chem Inf Model |
2019 |
| Rapid microarray-based assay for detection of pyrazinamide resistant Mycobacterium tuberculosis.
doi:10.1016/j.diagmicrobio.2018.12.011
|
Diagn Microbiol Infect Dis |
2019 |
| Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania.
doi:10.1186/s12879-019-3757-1
|
BMC Infect Dis |
2019 |
| Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
doi:10.1186/s12879-019-3764-2
names it
|
BMC Infect Dis |
2019 |
| Conventional and molecular determination of drug resistance in Mycobacterium tuberculosis and Mycobacterium bovis isolates in cattle.
doi:10.1016/j.tube.2018.12.005
|
Tuberculosis (Edinb) |
2019 |
| Application of next-generation sequencing to detect variants of drug-resistant Mycobacterium tuberculosis: genotype-phenotype correlation.
doi:10.1186/s12941-018-0300-y
|
Ann Clin Microbiol Antimicrob |
2019 |
| Characterization of novel Mycobacterium tuberculosis pncA gene mutations in clinical isolates from the Ukraine.
doi:10.1016/j.diagmicrobio.2018.10.018
names it
|
Diagn Microbiol Infect Dis |
2019 |
| Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study.
doi:10.1183/13993003.01770-2018
|
Eur Respir J |
2019 |
| Pyrazinamide resistance and mutations L19R, R140H, and E144K in Pyrazinamidase of Mycobacterium tuberculosis.
doi:10.1002/jcb.27989
|
J Cell Biochem |
2019 |
| Insights into the Mechanisms of the Pyrazinamide Resistance of Three Pyrazinamidase Mutants N11K, P69T, and D126N.
doi:10.1021/acs.jcim.8b00525
|
J Chem Inf Model |
2019 |
| A Diagnostic Algorithm To Investigate Pyrazinamide and Ethambutol Resistance in Rifampin-Resistant Mycobacterium tuberculosis Isolates in a Low-Incidence Setting.
doi:10.1128/AAC.01798-18
|
Antimicrob Agents Chemother |
2019 |
| pncA gene mutations in reporting pyrazinamide resistance among the MDR-TB suspects.
doi:10.1016/j.meegid.2018.11.012
names it
|
Infect Genet Evol |
2019 |
| MODS-Wayne, a Colorimetric Adaptation of the Microscopic-Observation Drug Susceptibility (MODS) Assay for Detection of Mycobacterium tuberculosis Pyrazinamide Resistance from Sputum Samples.
doi:10.1128/JCM.01162-18
|
J Clin Microbiol |
2019 |
| Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Indonesia.
doi:10.1016/j.jgar.2018.08.018
|
J Glob Antimicrob Resist |
2019 |
| Insight into novel clinical mutants of RpsA-S324F, E325K, and G341R of Mycobacterium tuberculosis associated with pyrazinamide resistance.
doi:10.1016/j.csbj.2018.09.004
|
Comput Struct Biotechnol J |
2018 |
| Whole-genome sequencing and single nucleotide polymorphisms in multidrug-resistant clinical isolates of Mycobacterium tuberculosis from the Philippines.
doi:10.1016/j.jgar.2018.08.009
|
J Glob Antimicrob Resist |
2018 |
| Characterization of pncA mutations in multi-drug and pyrazinamide resistant Mycobacterium tuberculosis isolates cultured from Queensland migrants and Papua New Guinea residents.
doi:10.1016/j.tube.2018.06.006
names it
|
Tuberculosis (Edinb) |
2018 |
| Is sequencing better than phenotypic tests for the detection of pyrazinamide resistance?
doi:10.5588/ijtld.17.0715
|
Int J Tuberc Lung Dis |
2018 |
| Computational discovery of potent drugs to improve the treatment of pyrazinamide resistant Mycobacterium tuberculosis mutants.
doi:10.1002/jcb.27033
|
J Cell Biochem |
2018 |
| Author Correction: Analysis of mutations in pncA reveals non-overlapping patterns among various lineages of Mycobacterium tuberculosis.
doi:10.1038/s41598-018-25809-7
names it
|
Sci Rep |
2018 |
| Analysis of a Novel pncA Mutation for Susceptibility to Pyrazinamide Therapy.
doi:10.1164/rccm.201712-2572LE
names it
|
Am J Respir Crit Care Med |
2018 |
| Novel Mutations in pncA Gene of Pyrazinamide Resistant Clinical Isolates of Mycobacterium tuberculosis.
doi:10.3390/scipharm86020015
names it
|
Sci Pharm |
2018 |
| Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates.
doi:10.3343/alm.2018.38.4.316
|
Ann Lab Med |
2018 |
| Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study.
doi:10.1016/S1473-3099(18)30073-2
|
Lancet Infect Dis |
2018 |
| Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia.
doi:10.1016/j.tube.2017.12.007
|
Tuberculosis (Edinb) |
2018 |
| Analysis of mutations in pncA reveals non-overlapping patterns among various lineages of Mycobacterium tuberculosis.
doi:10.1038/s41598-018-22883-9
names it
|
Sci Rep |
2018 |
| Estimation of pyrazinamidase activity using a cell-free In vitro synthesis of pnca and its association with pyrazinamide susceptibility in Mycobacterium tuberculosis.
doi:10.4103/ijmy.ijmy_187_17
names it
|
Int J Mycobacteriol |
2018 |
| Multi- and Extensively Drug Resistant Mycobacterium tuberculosis in South Africa: a Molecular Analysis of Historical Isolates.
doi:10.1128/JCM.01214-17
|
J Clin Microbiol |
2018 |
| Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national survey.
doi:10.5588/ijtld.17.0254
|
Int J Tuberc Lung Dis |
2018 |
| Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China.
doi:10.1016/j.cmi.2017.12.012
|
Clin Microbiol Infect |
2018 |
| Pyrazinamide Resistance among Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Myanmar.
doi:10.1128/AAC.01984-17
|
Antimicrob Agents Chemother |
2018 |
| Molecular drug resistance profiles of Mycobacterium tuberculosis from sputum specimens using ion semiconductor sequencing.
doi:10.1016/j.mimet.2017.12.003
|
J Microbiol Methods |
2018 |
| Detection of Mycobacterium tuberculosis pncA Mutations by the Nipro Genoscholar PZA-TB II Assay Compared to Conventional Sequencing.
doi:10.1128/AAC.01871-17
names it
|
Antimicrob Agents Chemother |
2018 |
| Role of pncA gene mutations W68R and W68G in pyrazinamide resistance.
doi:10.1002/jcb.26420
names it
|
J Cell Biochem |
2018 |
| Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment.
doi:10.1016/j.cmi.2017.05.026
|
Clin Microbiol Infect |
2018 |
| Mutation analysis for detection of drug resistance in mycobacterium tuberculosis isolates from Khyber Pakhtunkhwa, Pakistan.
|
J Pak Med Assoc |
2017 |
| Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
doi:10.1186/s12879-017-2761-6
|
BMC Infect Dis |
2017 |
| Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.
doi:10.1371/journal.pone.0187211
|
PLoS One |
2017 |
| A multiple genome analysis of Mycobacterium tuberculosis reveals specific novel genes and mutations associated with pyrazinamide resistance.
doi:10.1186/s12864-017-4146-z
|
BMC Genomics |
2017 |
| Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates.
doi:10.1038/emi.2017.73
|
Emerg Microbes Infect |
2017 |
| A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide.
doi:10.1038/s41467-017-00721-2
names it
|
Nat Commun |
2017 |
| Update of Antitubercular Prodrugs from a Molecular Perspective: Mechanisms of Action, Bioactivation Pathways, and Associated Resistance.
doi:10.1002/cmdc.201700424
|
ChemMedChem |
2017 |
| Improved Bactec MGIT 960 Pyrazinamide Test Decreases Detection of False Mycobacterium tuberculosis Pyrazinamide Resistance.
doi:10.1128/JCM.01437-17
|
J Clin Microbiol |
2017 |
| In Silico Prediction of Antibiotic Resistance in Mycobacterium ulcerans Agy99 through Whole Genome Sequence Analysis.
doi:10.4269/ajtmh.16-0478
|
Am J Trop Med Hyg |
2017 |
| Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia.
doi:10.1186/s12879-017-2594-3
names it
|
BMC Infect Dis |
2017 |
| A Multinational Analysis of Mutations and Heterogeneity in PZase, RpsA, and PanD Associated with Pyrazinamide Resistance in M/XDR Mycobacterium tuberculosis.
doi:10.1038/s41598-017-03452-y
|
Sci Rep |
2017 |
| Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh.
doi:10.1128/AAC.00511-17
names it
|
Antimicrob Agents Chemother |
2017 |
| Screening mutations in drug-resistant Mycobacterium tuberculosis strains in Yunnan, China.
doi:10.1016/j.jiph.2017.04.008
|
J Infect Public Health |
2017 |
| Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis.
doi:10.1128/AAC.00940-17
|
Antimicrob Agents Chemother |
2017 |
| Characterization of pyrazinamide resistance in consecutive multidrug-resistant mycobacterium tuberculosis isolates in sweden between 2003 and 2015.
doi:10.4103/ijmy.ijmy_23_17
|
Int J Mycobacteriol |
2017 |
| Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis.
doi:10.1371/journal.pone.0176522
|
PLoS One |
2017 |
| Performance of TaqMan array card to detect TB drug resistance on direct specimens.
doi:10.1371/journal.pone.0177167
|
PLoS One |
2017 |
| Detection of pyrazinamide resistance of Mycobacterium tuberculosis using nicotinamide as a surrogate.
doi:10.1016/j.cmi.2017.03.028
|
Clin Microbiol Infect |
2017 |
| Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That?
doi:10.1128/JCM.02532-16
names it
|
J Clin Microbiol |
2017 |
| pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia.
doi:10.3201/eid2303.161034
names it
|
Emerg Infect Dis |
2017 |
| FIND Tuberculosis Strain Bank: a Resource for Researchers and Developers Working on Tests To Detect Mycobacterium tuberculosis and Related Drug Resistance.
doi:10.1128/JCM.01662-16
|
J Clin Microbiol |
2017 |
| pncA mutations are associated with slower sputum conversion during standard treatment of multidrug-resistant tuberculosis.
doi:10.1016/j.ijantimicag.2016.10.012
names it
|
Int J Antimicrob Agents |
2017 |
| Long-Chain Fatty Acyl Coenzyme A Ligase FadD2 Mediates Intrinsic Pyrazinamide Resistance in Mycobacterium tuberculosis.
doi:10.1128/AAC.02130-16
|
Antimicrob Agents Chemother |
2017 |
| Insights into Pyrazinamidase and DNA Gyrase Protein Structures in Resistant and Susceptible Clinical Isolates of Mycobacterium tuberculosis.
|
Tanaffos |
2016 |
| New insights into the mechanism of action of pyrazinamide, implications for susceptibility testing, and future regimens.
doi:10.1016/j.ijmyco.2016.08.009
|
Int J Mycobacteriol |
2016 |
| The majority of patients with multidrug-resistant tuberculosis in Sub-Saharan Africa present a concomitant resistance to pyrazinamide.
doi:10.1016/j.ijmyco.2016.10.015
|
Int J Mycobacteriol |
2016 |
| Best approaches to drug-resistance surveillance at the country level.
doi:10.1016/j.ijmyco.2016.09.010
|
Int J Mycobacteriol |
2016 |
| Impact of genotypic and phenotypic resistance to second-line anti-tuberculosis drugs on treatment outcomes in multidrug-resistant tuberculosis in China.
doi:10.1016/j.ijmyco.2016.11.007
|
Int J Mycobacteriol |
2016 |
| Pyrazinamide susceptibility testing: proposed new standard with the BACTECTM MGITTM 960 system.
doi:10.5588/ijtld.16.0360
|
Int J Tuberc Lung Dis |
2016 |
| Detecting Mutations in the Mycobacterium tuberculosis Pyrazinamidase Gene pncA to Improve Infection Control and Decrease Drug Resistance Rates in Human Immunodeficiency Virus Coinfection.
doi:10.4269/ajtmh.15-0711
names it
|
Am J Trop Med Hyg |
2016 |
| Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.
doi:10.1186/s12879-016-1906-3
|
BMC Infect Dis |
2016 |
| Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.
doi:10.1128/AAC.00632-16
|
Antimicrob Agents Chemother |
2016 |
| Genotypic characterization of drug resistant Mycobacterium tuberculosis in Quebec, 2002-2012.
doi:10.1186/s12866-016-0786-4
|
BMC Microbiol |
2016 |
| Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosis.
doi:10.1016/j.tube.2016.05.003
|
Tuberculosis (Edinb) |
2016 |
| A quantitative adaptation of the Wayne test for pyrazinamide resistance.
doi:10.1016/j.tube.2016.03.011
|
Tuberculosis (Edinb) |
2016 |
| Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project.
doi:10.1016/S1473-3099(16)30190-6
|
Lancet Infect Dis |
2016 |
| Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in China.
doi:10.1128/AAC.02687-15
|
Antimicrob Agents Chemother |
2016 |
| Prevalence and transmission of pyrazinamide resistant Mycobacterium tuberculosis in China.
doi:10.1016/j.tube.2016.02.008
|
Tuberculosis (Edinb) |
2016 |
| High Systemic Exposure of Pyrazinoic Acid Has Limited Antituberculosis Activity in Murine and Rabbit Models of Tuberculosis.
doi:10.1128/AAC.03085-15
|
Antimicrob Agents Chemother |
2016 |
| Pyrazinamide resistance among multidrug-resistant tuberculosis clinical isolates in a national referral center of China and its correlations with pncA, rpsA, and panD gene mutations.
doi:10.1016/j.diagmicrobio.2015.10.017
names it
|
Diagn Microbiol Infect Dis |
2016 |
| A Novel Molecular Strategy for Surveillance of Multidrug Resistant Tuberculosis in High Burden Settings.
doi:10.1371/journal.pone.0146106
|
PLoS One |
2016 |
| The draft genome of Mycobacterium aurum, a potential model organism for investigating drugs against Mycobacterium tuberculosis and Mycobacterium leprae.
doi:10.1016/j.ijmyco.2015.05.001
|
Int J Mycobacteriol |
2015 |
| Genome sequence comparisons of serial multi-drug-resistant Mycobacterium tuberculosis isolates over 21 years of infection in a single patient.
doi:10.1099/mgen.0.000037
|
Microb Genom |
2015 |
| Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
doi:10.1371/journal.pmed.1001880
|
PLoS Med |
2015 |
| Improved Detection by Next-Generation Sequencing of Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates.
doi:10.1128/JCM.01179-15
|
J Clin Microbiol |
2015 |
| Uncoupling Environmental pH and Intrabacterial Acidification from Pyrazinamide Susceptibility in Mycobacterium tuberculosis.
doi:10.1128/AAC.00967-15
|
Antimicrob Agents Chemother |
2015 |
| Mycobacterium tuberculosis pncA Polymorphisms That Do Not Confer Pyrazinamide Resistance at a Breakpoint Concentration of 100 Micrograms per Milliliter in MGIT.
doi:10.1128/JCM.01001-15
names it
|
J Clin Microbiol |
2015 |
| A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis.
doi:10.1371/journal.pone.0133869
|
PLoS One |
2015 |
| Epidemiologic Correlates of Pyrazinamide-Resistant Mycobacterium tuberculosis in New York City.
doi:10.1128/AAC.00764-15
|
Antimicrob Agents Chemother |
2015 |
| Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates.
doi:10.1128/AAC.00204-15
|
Antimicrob Agents Chemother |
2015 |
| Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960.
doi:10.1016/j.tube.2015.05.013
names it
|
Tuberculosis (Edinb) |
2015 |
| Genome sequencing reveals novel deletions associated with secondary resistance to pyrazinamide in MDR Mycobacterium tuberculosis.
doi:10.1093/jac/dkv128
|
J Antimicrob Chemother |
2015 |
| Biochemical Characterization and Computational Identification of Mycobacterium tuberculosis Pyrazinamidase in Some Pyrazinamide-Resistant Isolates of Iran.
doi:10.1007/s10930-015-9610-5
|
Protein J |
2015 |
| The indirect microscopic observation drug susceptibility assay demonstrated high concordance with the indirect MGIT method for pyrazinamide susceptibility testing.
doi:10.1093/jac/dkv112
|
J Antimicrob Chemother |
2015 |
| Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance.
doi:10.5588/ijtld.14.0768
|
Int J Tuberc Lung Dis |
2015 |
| Pyrazinamide: the importance of uncovering the mechanisms of action in mycobacteria.
doi:10.1586/14787210.2015.1021784
|
Expert Rev Anti Infect Ther |
2015 |
| Whole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from Pakistan.
doi:10.1371/journal.pone.0117771
|
PLoS One |
2015 |
| Integrated microfluidic card with TaqMan probes and high-resolution melt analysis to detect tuberculosis drug resistance mutations across 10 genes.
doi:10.1128/mBio.02273-14
|
mBio |
2015 |
| Mechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosis pyrazinamidase enzyme and pyrazinamide susceptibility.
doi:10.1186/1471-2164-16-S2-S14
|
BMC Genomics |
2015 |
| Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Zhejiang, China.
doi:10.1128/AAC.04541-14
|
Antimicrob Agents Chemother |
2015 |
| Mutations in the pncA and rpsA genes among 77 Mycobacterium tuberculosis isolates in Kazakhstan.
doi:10.5588/ijtld.14.0305
names it
|
Int J Tuberc Lung Dis |
2015 |
| Multiple drug-susceptibility screening in Mycobacterium bovis: new nucleotide polymorphisms in the embB gene among ethambutol susceptible strains.
doi:10.1016/j.ijid.2014.12.043
|
Int J Infect Dis |
2015 |
| Mechanisms of Pyrazinamide Action and Resistance.
doi:10.1128/microbiolspec.MGM2-0023-2013
|
Microbiol Spectr |
2014 |
| Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis.
doi:10.1038/emi.2014.61
|
Emerg Microbes Infect |
2014 |
| Multiplex-PCR for differentiation of Mycobacterium bovis from Mycobacterium tuberculosis complex.
doi:10.1590/s1517-83822014000300012
|
Braz J Microbiol |
2014 |
| Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study.
doi:10.1128/mBio.01819-14
|
mBio |
2014 |
| Rapid sequencing of the Mycobacterium tuberculosis pncA gene for detection of pyrazinamide susceptibility.
doi:10.1128/JCM.02438-14
names it
|
J Clin Microbiol |
2014 |
| Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Korea and analysis of the correlation between the mutations and pyrazinamidase activity.
doi:10.1007/s11274-014-1706-0
names it
|
World J Microbiol Biotechnol |
2014 |
| Evaluation of a biphasic media assay for pyrazinamide drug susceptibility testing of Mycobacterium tuberculosis.
doi:10.1093/jac/dku230
|
J Antimicrob Chemother |
2014 |
| Outbreak of pyrazinamide-monoresistant tuberculosis identified using genotype cluster and social media analysis.
doi:10.5588/ijtld.13.0663
|
Int J Tuberc Lung Dis |
2014 |
| Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm.
doi:10.1111/1469-0691.12696
|
Clin Microbiol Infect |
2014 |
| Association between pncA gene mutations, pyrazinamidase activity, and pyrazinamide susceptibility testing in Mycobacterium tuberculosis.
doi:10.1128/AAC.02394-14
names it
|
Antimicrob Agents Chemother |
2014 |
| Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hunan, China.
doi:10.1128/AAC.02426-14
|
Antimicrob Agents Chemother |
2014 |
| MUBII-TB-DB: a database of mutations associated with antibiotic resistance in Mycobacterium tuberculosis.
doi:10.1186/1471-2105-15-107
|
BMC Bioinformatics |
2014 |
| Characterization of the etiological agents of tuberculous lymphadenitis in Dera Woreda, North Showa, Ethiopia.
|
Ethiop Med J |
2014 |
| Characterisation of pyrazinamide-resistant Mycobacterium tuberculosis strains isolated in Poland and Germany.
doi:10.5588/ijtld.13.0457
|
Int J Tuberc Lung Dis |
2014 |
| Evidence of Clonal Expansion in the Genome of a Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolate from Peru.
doi:10.1128/genomeA.00089-14
|
Genome Announc |
2014 |
| Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis.
doi:10.1016/j.tube.2013.10.006
|
Tuberculosis (Edinb) |
2014 |
| Rapid detection of Mycobacterium tuberculosis and pyrazinamide susceptibility related to pncA mutations in sputum specimens through an integrated gene-to-protein function approach.
doi:10.1128/JCM.02285-13
names it
|
J Clin Microbiol |
2014 |
| Role of pncA and rpsA gene sequencing in detection of pyrazinamide resistance in Mycobacterium tuberculosis isolates from southern China.
doi:10.1128/JCM.01903-13
names it
|
J Clin Microbiol |
2014 |
| Drug resistance mechanism of PncA in Mycobacterium tuberculosis.
doi:10.1080/07391102.2012.759885
names it
|
J Biomol Struct Dyn |
2014 |
| Multidrug-resistant Myobacterium tuberculosis caused by the Beijing genotype and a specific T1 genotype clone (SIT No. 266) is widely transmitted in Minsk.
doi:10.1016/j.ijmyco.2013.08.001
|
Int J Mycobacteriol |
2013 |
| Performance of the microscopic observation drug susceptibility assay in pyrazinamide susceptibility testing for Mycobacterium tuberculosis.
|
Chin Med J (Engl) |
2013 |
| Rapid detection of pyrazinamide resistant Mycobacterium tuberculosis by high resolution melting curve analysis.
|
J Med Assoc Thai |
2013 |
| Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience.
doi:10.5588/ijtld.13.0195
|
Int J Tuberc Lung Dis |
2013 |
| Primary multidrug-resistant Mycobacterium tuberculosis in 2 regions, Eastern Siberia, Russian Federation.
doi:10.3201/eid1910.121108
|
Emerg Infect Dis |
2013 |
| Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania.
doi:10.1186/1471-2334-13-432
|
BMC Infect Dis |
2013 |
| pncA gene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis.
doi:10.1016/j.tube.2013.03.005
names it
|
Tuberculosis (Edinb) |
2013 |
| [Detection of pncA mutation associated with pyrazinamide resistance in Mycobacterium tuberculosis by high-resolution melting cure analysis].
names it
|
Zhonghua Jie He He Hu Xi Za Zhi |
2013 |
| Tuberculosis patients co-infected with Mycobacterium bovis and Mycobacterium tuberculosis in an urban area of Brazil.
doi:10.1590/S0074-02762013000300010
|
Mem Inst Oswaldo Cruz |
2013 |
| Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene.
doi:10.1016/j.meegid.2013.06.008
names it
|
Infect Genet Evol |
2013 |
| Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis.
doi:10.1038/emi.2013.38
|
Emerg Microbes Infect |
2013 |
| Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
doi:10.1016/j.diagmicrobio.2013.02.035
|
Diagn Microbiol Infect Dis |
2013 |
| Mycobacterium canettii is intrinsically resistant to both pyrazinamide and pyrazinoic acid.
doi:10.1093/jac/dkt042
|
J Antimicrob Chemother |
2013 |
| Density functional and molecular docking studies towards investigating the role of single-wall carbon nanotubes as nanocarrier for loading and delivery of pyrazinamide antitubercular drug onto pncA protein.
doi:10.1007/s10822-013-9638-6
names it
|
J Comput Aided Mol Des |
2013 |
| Evaluation of methods for testing the susceptibility of clinical Mycobacterium tuberculosis isolates to pyrazinamide.
doi:10.1128/JCM.03197-12
|
J Clin Microbiol |
2013 |
| Base-calling algorithm with vocabulary (BCV) method for analyzing population sequencing chromatograms.
doi:10.1371/journal.pone.0054835
|
PLoS One |
2013 |
| Characterization of pncA gene mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Mexico.
doi:10.1016/j.meegid.2012.12.013
names it
|
Infect Genet Evol |
2013 |
| Mechanisms of Pyrazinamide Action and Resistance.
doi:10.1128/microbiolspec.MGM2-0023-2013
|
Microbiol Spectr |
2013 |
| Prevention of false resistance results obtained in testing the susceptibility of Mycobacterium tuberculosis to pyrazinamide with the Bactec MGIT 960 system using a reduced inoculum.
doi:10.1128/JCM.01838-12
|
J Clin Microbiol |
2013 |
| Phenotypic and genotypic characteristics of drug resistance in Mycobacterium tuberculosis isolates from pediatric population of Chennai, India.
doi:10.4103/0255-0857.103761
|
Indian J Med Microbiol |
2012 |
| pncA Mutations in the Specimens from Extrapulmonary Tuberculosis.
doi:10.4046/trd.2012.72.6.475
names it
|
Tuberc Respir Dis (Seoul) |
2012 |
| Next-generation ion torrent sequencing of drug resistance mutations in Mycobacterium tuberculosis strains.
doi:10.1128/JCM.01893-12
|
J Clin Microbiol |
2012 |
| Gene sequencing for routine verification of pyrazinamide resistance in Mycobacterium tuberculosis: a role for pncA but not rpsA.
doi:10.1128/JCM.00620-12
names it
|
J Clin Microbiol |
2012 |
| [Characteristics of pncA gene in multidrug-resistant Mycobacterium tuberculosis isolates and its correlation with drug resistance to pyrazinamide].
names it
|
Zhonghua Yu Fang Yi Xue Za Zhi |
2012 |
| Systematic analysis of pyrazinamide-resistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis.
doi:10.1128/AAC.05385-11
|
Antimicrob Agents Chemother |
2012 |
| Molecular dynamics simulations suggest ligand's binding to nicotinamidase/pyrazinamidase.
doi:10.1371/journal.pone.0039546
|
PLoS One |
2012 |
| 'Z(S)-MDR-TB' versus 'Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility.
doi:10.1038/emi.2012.18
|
Emerg Microbes Infect |
2012 |
| Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence setting.
doi:10.1186/1471-2180-12-90
|
BMC Microbiol |
2012 |
| Filterable forms and L-forms of Mycobacterium bovis BCG: impact for live vaccine features.
doi:10.4161/hv.19698
|
Hum Vaccin Immunother |
2012 |
| Drug resistance of Mycobacterium tuberculosis strains in southern Brazil.
doi:10.1590/s0037-86822012000100018
|
Rev Soc Bras Med Trop |
2012 |
| Detection and identification of Mycobacterium tuberculosis and Mycobacterium bovis from clinical species using DNA microarrays.
doi:10.1177/1040638711417141
|
J Vet Diagn Invest |
2012 |
| Pyrazinamide: a frontline drug used for tuberculosis. Molecular mechanism of action resolved after 50 years?
doi:10.1002/cmdc.201100587
|
ChemMedChem |
2012 |
| Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosis.
doi:10.5588/ijtld.11.0266
|
Int J Tuberc Lung Dis |
2012 |
| Patterns of pncA mutations in drug-resistant Mycobacterium tuberculosis isolated from patients in South Korea.
doi:10.5588/ijtld.10.0739
names it
|
Int J Tuberc Lung Dis |
2012 |
| Reevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene sequencing.
doi:10.1128/AAC.05894-11
names it
|
Antimicrob Agents Chemother |
2012 |
| Validation of pncA gene sequencing in combination with the mycobacterial growth indicator tube method to test susceptibility of Mycobacterium tuberculosis to pyrazinamide.
doi:10.1128/JCM.05435-11
names it
|
J Clin Microbiol |
2012 |
| Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.
doi:10.1016/j.tube.2011.09.002
|
Tuberculosis (Edinb) |
2012 |
| Rapid colorimetric testing for pyrazinamide susceptibility of M. tuberculosis by a PCR-based in-vitro synthesized pyrazinamidase method.
doi:10.1371/journal.pone.0027654
|
PLoS One |
2011 |
| Characteristics of pncA mutations in multidrug-resistant tuberculosis in Taiwan.
doi:10.1186/1471-2334-11-240
names it
|
BMC Infect Dis |
2011 |
| Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis.
doi:10.1126/science.1208813
|
Science |
2011 |
| Structure-Activity relationship in mutated pyrazinamidases from Mycobacterium tuberculosis.
doi:10.6026/97320630006335
|
Bioinformation |
2011 |
| Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses.
doi:10.1128/AAC.00630-11
|
Antimicrob Agents Chemother |
2011 |
| The Guinea-Bissau family of Mycobacterium tuberculosis complex revisited.
doi:10.1371/journal.pone.0018601
|
PLoS One |
2011 |
| Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
doi:10.1128/AAC.01550-10
|
Antimicrob Agents Chemother |
2011 |
| Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide.
doi:10.1371/journal.pone.0015785
|
PLoS One |
2011 |
| Kinetics and inhibition of nicotinamidase from Mycobacterium tuberculosis.
doi:10.1021/bi1011157
|
Biochemistry |
2010 |
| Mutually exclusive genotypes for pyrazinamide and 5-chloropyrazinamide resistance reveal a potential resistance-proofing strategy.
doi:10.1128/AAC.00529-10
|
Antimicrob Agents Chemother |
2010 |
| Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.
doi:10.1186/1471-2180-10-223
|
BMC Microbiol |
2010 |
| Molecular epidemiological study of pyrazinamide-resistance in clinical isolates of mycobacterium tuberculosis from South India.
doi:10.3390/ijms11072670
|
Int J Mol Sci |
2010 |
| Evaluation of colorimetric methods using nicotinamide for rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis.
doi:10.1128/JCM.00311-10
|
J Clin Microbiol |
2010 |
| Rapid identification of multidrug-resistant tuberculosis isolates in treatment failure or relapse patients in Bangui, Central African Republic.
|
Int J Tuberc Lung Dis |
2010 |
| The near future: improving the activity of rifamycins and pyrazinamide.
doi:10.1016/j.tube.2010.03.005
|
Tuberculosis (Edinb) |
2010 |
| NAD+ auxotrophy is bacteriocidal for the tubercle bacilli.
doi:10.1111/j.1365-2958.2010.07099.x
|
Mol Microbiol |
2010 |
| Determination of the susceptibility of Mycobacterium tuberculosis to pyrazinamide in liquid and solid media assessed by a colorimetric nitrate reductase assay.
doi:10.1093/jac/dkp506
|
J Antimicrob Chemother |
2010 |
| Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide resistance.
doi:10.1016/j.meegid.2009.11.016
|
Infect Genet Evol |
2010 |
| Potential for erroneous results indicating resistance when using the Bactec MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide.
doi:10.1128/JCM.01775-09
|
J Clin Microbiol |
2010 |
| Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan.
doi:10.1111/j.1469-0691.2009.03078.x
|
Clin Microbiol Infect |
2010 |
| Clinical efficacy of direct DNA sequencing analysis on sputum specimens for early detection of drug-resistant Mycobacterium tuberculosis in a clinical setting.
doi:10.1378/chest.09-0150
|
Chest |
2010 |
| Insight to pyrazinamide resistance in Mycobacterium tuberculosis by molecular docking.
doi:10.6026/97320630004024
|
Bioinformation |
2009 |
| Mutations found in the pncA gene of Mycobacterium tuberculosis in clinical pyrazinamide-resistant isolates from a local region of China.
doi:10.1177/147323000903700517
names it
|
J Int Med Res |
2009 |
| Characterisation of pncA mutations in clinical Mycobacterium tuberculosis isolates in New Zealand.
doi:10.1080/00313020903071587
names it
|
Pathology |
2009 |
| Genome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa.
doi:10.1371/journal.pone.0007778
|
PLoS One |
2009 |
| Mycobacterium tuberculosis genotypic diversity in pyrazinamide-resistant isolates of Iran.
doi:10.1089/mdr.2009.0066
|
Microb Drug Resist |
2009 |
| Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing.
|
Indian J Tuberc |
2009 |
| Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Turkey.
names it
|
New Microbiol |
2009 |
| Sputum PCR-single-strand conformational polymorphism test for same-day detection of pyrazinamide resistance in tuberculosis patients.
doi:10.1128/JCM.01594-08
|
J Clin Microbiol |
2009 |
| Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis.
doi:10.1016/j.tube.2009.01.004
|
Tuberculosis (Edinb) |
2009 |
| In-depth molecular characterization of Mycobacterium tuberculosis from New Delhi--predominance of drug resistant isolates of the 'modern' (TbD1) type.
doi:10.1371/journal.pone.0004540
|
PLoS One |
2009 |
| Molecular detection of drug-resistant Mycobacterium tuberculosis with a scanning-frame oligonucleotide microarray.
doi:10.1007/978-1-59745-207-6_26
|
Methods Mol Biol |
2009 |
| [Determining drug resistance of the clinical strains of Mycobacterium tuberculosis to pyrazinamide].
|
Mol Gen Mikrobiol Virusol |
2008 |
| Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates.
doi:10.1128/JCM.00973-08
|
J Clin Microbiol |
2008 |
| Phenotypic and genotypic characterization of drug-resistant Mycobacterium tuberculosis strains.
doi:10.1016/j.diagmicrobio.2008.06.013
|
Diagn Microbiol Infect Dis |
2008 |
| A single-step sequencing method for the identification of Mycobacterium tuberculosis complex species.
doi:10.1371/journal.pntd.0000253
|
PLoS Negl Trop Dis |
2008 |
| Multidrug-resistant tuberculosis in Lisbon, Portugal: a molecular epidemiological perspective.
doi:10.1089/mdr.2008.0798
|
Microb Drug Resist |
2008 |
| Pyrazinamide resistance and pncA gene mutations in Mycobacterium tuberculosis.
doi:10.1128/AAC.00110-08
names it
|
Antimicrob Agents Chemother |
2008 |
| Geography and genealogy of the human host harbouring a distinctive drug-resistant strain of tuberculosis.
doi:10.1016/j.meegid.2007.11.008
|
Infect Genet Evol |
2008 |
| Characterization of Mycobacterium tuberculosis nicotinamidase/pyrazinamidase.
doi:10.1111/j.1742-4658.2007.06241.x
|
FEBS J |
2008 |
| Nitrate reductase assay for the rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide.
doi:10.1093/jac/dkm418
|
J Antimicrob Chemother |
2008 |
| Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide.
doi:10.1093/jac/dkm252
|
J Antimicrob Chemother |
2007 |
| Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant mycobacterium tuberculosis strains.
doi:10.1128/JCM.00352-07
names it
|
J Clin Microbiol |
2007 |
| Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong.
doi:10.1093/jac/dkm054
|
J Antimicrob Chemother |
2007 |
| Discrepant results between pyrazinamide susceptibility testing by the reference BACTEC 460TB method and pncA DNA sequencing in patients infected with multidrug-resistant W-Beijing Mycobacterium tuberculosis strains.
doi:10.1378/chest.06-1899
names it
|
Chest |
2007 |
| Sequencing of the pncA gene in members of the Mycobacterium tuberculosis complex has important diagnostic applications: Identification of a species-specific pncA mutation in "Mycobacterium canettii" and the reliable and rapid predictor of pyrazinamide resistance.
doi:10.1128/JCM.01454-06
names it
|
J Clin Microbiol |
2007 |
| Detection of multidrug resistance in Mycobacterium tuberculosis.
doi:10.1128/JCM.00750-06
|
J Clin Microbiol |
2007 |
| The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria.
|
J Commun Dis |
2006 |
| pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil.
doi:10.1093/jac/dkl363
names it
|
J Antimicrob Chemother |
2006 |
| Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients.
|
Int J Tuberc Lung Dis |
2006 |
| A new rapid and simple colorimetric method to detect pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide.
doi:10.1093/jac/dkl231
|
J Antimicrob Chemother |
2006 |
| Detection of Mycobacterium avium & M. tuberculosis from human sputum cultures by PCR-RFLP analysis of hsp65 gene & pncA PCR.
names it
|
Indian J Med Res |
2006 |
| Temperature-mediated heteroduplex analysis for the detection of drug-resistant gene mutations in clinical isolates of Mycobacterium tuberculosis by denaturing HPLC, SURVEYOR nuclease.
doi:10.1016/j.micinf.2005.06.008
|
Microbes Infect |
2006 |
| Spoligotyping and pncA polymorphism: a two step scenario for Mycobacterium bovis diagnosis in Portugal.
doi:10.1016/s0873-2159(15)30528-6
names it
|
Rev Port Pneumol |
2005 |
| Microarray-based pncA genotyping of pyrazinamide-resistant strains of Mycobacterium tuberculosis.
doi:10.1099/jmm.0.46129-0
names it
|
J Med Microbiol |
2005 |
| [Resistance to antituberculous drugs].
doi:10.1016/s0929-693x(05)80024-7
|
Arch Pediatr |
2005 |
| Detection by denaturing gradient gel electrophoresis of pncA mutations associated with pyrazinamide resistance in Mycobacterium tuberculosis isolates from the United States-Mexico border region.
doi:10.1128/AAC.49.6.2210-2217.2005
names it
|
Antimicrob Agents Chemother |
2005 |
| Analysis of rpoB and pncA mutations in the published literature: an insight into the role of oxidative stress in Mycobacterium tuberculosis evolution?
doi:10.1093/jac/dki069
names it
|
J Antimicrob Chemother |
2005 |
| Simple fibroblast-based assay to test the pyrazinamide susceptibility of Mycobacterium tuberculosis.
doi:10.1128/AAC.49.2.804-807.2005
|
Antimicrob Agents Chemother |
2005 |
| Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil.
doi:10.1128/AAC.49.1.444-446.2005
names it
|
Antimicrob Agents Chemother |
2005 |
| Characterization of drug-resistant isolates of Mycobacterium tuberculosis derived from Russian inmates.
|
Int J Tuberc Lung Dis |
2004 |
| Molecular strain identification of the Mycobacterium tuberculosis complex in archival tissue samples.
doi:10.1136/jcp.2003.015719
|
J Clin Pathol |
2004 |
| Silent nucleotide polymorphisms and a phylogeny for Mycobacterium tuberculosis.
doi:10.3201/eid1009.040046
|
Emerg Infect Dis |
2004 |
| [Molecular identification of mycobacteria and detection of antibiotic resistance].
|
Ann Biol Clin (Paris) |
2004 |
| Calmette-Guérin bacillus sternal osteomyelitis diagnosed by DNA sequencing analysis of PNC A.
doi:10.1097/01.inf.0000134311.89819.fd
|
Pediatr Infect Dis J |
2004 |
| Spectrum of pncA mutations in multidrug-resistant Mycobacterium tuberculosis isolates obtained in Latvia.
doi:10.1128/AAC.48.8.3209-3210.2004
names it
|
Antimicrob Agents Chemother |
2004 |
| pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates in Portugal.
doi:10.1128/AAC.48.7.2736-2738.2004
names it
|
Antimicrob Agents Chemother |
2004 |
| Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis.
doi:10.1086/421501
|
J Infect Dis |
2004 |
| Genomic characterization of an endemic Mycobacterium tuberculosis strain: evolutionary and epidemiologic implications.
doi:10.1128/JCM.42.6.2573-2580.2004
|
J Clin Microbiol |
2004 |
| Accurate mapping of mutations of pyrazinamide-resistant Mycobacterium tuberculosis strains with a scanning-frame oligonucleotide microarray.
doi:10.1016/j.diagmicrobio.2004.01.001
|
Diagn Microbiol Infect Dis |
2004 |
| A pncA polymorphism to differentiate between Mycobacterium bovis and Mycobacterium tuberculosis.
doi:10.1016/j.mcp.2003.11.006
names it
|
Mol Cell Probes |
2004 |
| BCG lymphadenopathy detected in a BCG-vaccinated infant.
doi:10.1590/s0100-879x2004000500011
|
Braz J Med Biol Res |
2004 |
| The 500-base-pair fragment of the putative gene RvD1-Rv2031c is also present in the genome of Mycobacterium tuberculosis.
|
In Vivo |
2004 |
| Temperature-mediated heteroduplex analysis for detection of pncA mutations associated with pyrazinamide resistance and differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by denaturing high- performance liquid chromatography.
doi:10.1128/JCM.42.3.1016-1023.2004
names it
|
J Clin Microbiol |
2004 |
| Genetic and phenotypic characterization of pyrazinamide-resistant mycobacterium tuberculosis complex isolates in Japan.
doi:10.1016/j.diagmicrobio.2003.09.013
|
Diagn Microbiol Infect Dis |
2004 |
| Elevation of Mycobacterium tuberculosis subsp. caprae Aranaz et al. 1999 to species rank as Mycobacterium caprae comb. nov., sp. nov.
doi:10.1099/ijs.0.02532-0
|
Int J Syst Evol Microbiol |
2003 |
| [Tuberculous epididymitis caused by intravesical BCG therapy: a case report].
|
Hinyokika Kiyo |
2003 |
| Correlation between pyrazinamide activity and pncA mutations in Mycobacterium tuberculosis isolates in Taiwan.
doi:10.1128/AAC.47.11.3672-3673.2003
names it
|
Antimicrob Agents Chemother |
2003 |
| Widespread pyrazinamide-resistant Mycobacterium tuberculosis family in a low-incidence setting.
doi:10.1128/JCM.41.7.2878-2883.2003
|
J Clin Microbiol |
2003 |
| An assessment of a multiplex PCR assay for differentiating clinically important mycobacteria based on pncA gene variation.
doi:10.1016/s0890-8508(03)00004-5
names it
|
Mol Cell Probes |
2003 |
| The curious characteristics of pyrazinamide: a review.
|
Int J Tuberc Lung Dis |
2003 |
| Evaluation of BACTEC MGIT 960 PZA medium for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide (PZA): compared with the results of pyrazinamidase assay and Kyokuto PZA test.
doi:10.1016/s0732-8893(02)00471-6
|
Diagn Microbiol Infect Dis |
2002 |
| [Clinical application and evaluation of the detection of five drugs resistance genes in Mycobacterium tuberculosis].
|
Zhonghua Jie He He Hu Xi Za Zhi |
2002 |
| Identification of the causative organism of tuberculous lymphadenitis in ethiopia by PCR.
doi:10.1128/JCM.40.11.4230-4234.2002
|
J Clin Microbiol |
2002 |
| Selection of in vitro mutants of pyrazinamide-resistant Mycobacterium tuberculosis.
doi:10.1016/s0924-8579(02)00182-6
|
Int J Antimicrob Agents |
2002 |
| A multiplex-PCR for the differentiation of Mycobacterium bovis and Mycobacterium tuberculosis.
doi:10.1111/j.1574-6968.2002.tb11322.x
|
FEMS Microbiol Lett |
2002 |
| Characterization of pyrazinamide and ofloxacin resistance among drug resistant Mycobacterium tuberculosis isolates from Singapore.
doi:10.1016/s1201-9712(02)90136-0
|
Int J Infect Dis |
2002 |
| Pyrazinamide resistance associated with pncA gene mutation in Mycobacterium tuberculosis in Japan.
doi:10.1017/s0950268801006744
names it
|
Epidemiol Infect |
2002 |
| Temperature-mediated heteroduplex analysis performed by using denaturing high-performance liquid chromatography to identify sequence polymorphisms in Mycobacterium tuberculosis complex organisms.
doi:10.1128/JCM.40.5.1610-1616.2002
|
J Clin Microbiol |
2002 |
| Biochemical and genetic evidence for the transfer of Mycobacterium tuberculosis subsp. caprae Aranaz et al. 1999 to the species Mycobacterium bovis Karlson and Lessel 1970 (approved lists 1980) as Mycobacterium bovis subsp. caprae comb. nov.
doi:10.1099/00207713-52-2-433
|
Int J Syst Evol Microbiol |
2002 |
| Rapid detection of pyrazinamide-resistant Mycobacterium tuberculosis by a PCR-based in vitro system.
doi:10.1128/JCM.40.2.501-507.2002
|
J Clin Microbiol |
2002 |
| New mutations in pncA of in vitro selected pyrazinamide-resistant strains of Mycobacterium tuberculosis.
doi:10.1089/10766290152652765
names it
|
Microb Drug Resist |
2001 |
| Genetic diversity among Mycobacterium bovis isolates: a preliminary study of strains from animal and human sources.
doi:10.1128/JCM.39.12.4558-4562.2001
|
J Clin Microbiol |
2001 |
| Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea.
doi:10.3346/jkms.2001.16.5.537
names it
|
J Korean Med Sci |
2001 |
| Characterisation of the pncA gene in Mycobacterium tuberculosis isolates from Gauteng, South Africa.
names it
|
Int J Tuberc Lung Dis |
2001 |
| pncA mutations in clinical Mycobacterium tuberculosis isolates from Korea.
doi:10.1186/1471-2334-1-4
names it
|
BMC Infect Dis |
2001 |
| Study of the structure-activity relationships for the pyrazinamidase (PncA) from Mycobacterium tuberculosis.
doi:10.1042/0264-6021:3530453
names it
|
Biochem J |
2001 |
| Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States.
doi:10.1128/JCM.39.2.647-650.2001
|
J Clin Microbiol |
2001 |
| Genetic diversity of Mycobacterium africanum clinical isolates based on IS6110-restriction fragment length polymorphism analysis, spoligotyping, and variable number of tandem DNA repeats.
doi:10.1128/JCM.39.1.57-65.2001
|
J Clin Microbiol |
2001 |
| [Studies on pncA gene mutations in M. tuberculosis isolates].
names it
|
Zhonghua Jie He He Hu Xi Za Zhi |
2000 |
| Correlation of pncA sequence with pyrazinamide resistance level in BACTEC for 21 mycobacterium tuberculosis clinical isolates.
doi:10.1089/mdr.2000.6.283
names it
|
Microb Drug Resist |
2000 |
| Genetic diversity and evidence for acquired antimicrobial resistance in Mycobacterium tuberculosis at a large hospital in South India.
doi:10.1016/s1201-9712(00)90075-4
|
Int J Infect Dis |
2000 |
| [Molecular mechanisms of multidrug resistance in Mycobacterium tuberculosis].
doi:10.7888/juoeh.22.269
|
J UOEH |
2000 |
| Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing with Mycobacterium tuberculosis.
doi:10.1128/JCM.38.10.3686-3688.2000
|
J Clin Microbiol |
2000 |
| Genotypic determination of Mycobacterium tuberculosis antibiotic resistance using a novel mutation detection method, the branch migration inhibition M. tuberculosis antibiotic resistance test.
doi:10.1128/JCM.38.10.3656-3662.2000
|
J Clin Microbiol |
2000 |
| Expression of Mycobacterium smegmatis pyrazinamidase in Mycobacterium tuberculosis confers hypersensitivity to pyrazinamide and related amides.
doi:10.1128/JB.182.19.5479-5485.2000
|
J Bacteriol |
2000 |
| Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.
doi:10.1128/AAC.44.9.2291-2295.2000
names it
|
Antimicrob Agents Chemother |
2000 |
| Simultaneous identification and typing of multi-drug-resistant Mycobacterium tuberculosis isolates by analysis of pncA and rpoB.
doi:10.1099/0022-1317-49-7-651
names it
|
J Med Microbiol |
2000 |
| Mycobacterium smegmatis has two pyrazinamidase enzymes, PncA and pzaA.
doi:10.1128/JB.182.13.3881-3884.2000
names it
|
J Bacteriol |
2000 |
| Molecular characterization of pncA gene mutations in Mycobacterium tuberculosis clinical isolates from China.
doi:10.1017/s0950268899003635
names it
|
Epidemiol Infect |
2000 |
| pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.
doi:10.1128/AAC.44.3.528-532.2000
names it
|
Antimicrob Agents Chemother |
2000 |
| Molecular characterization of mycobacteria isolated from seals.
doi:10.1099/00221287-145-9-2519
|
Microbiology (Reading) |
1999 |
| Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.
doi:10.1128/AAC.43.9.2317
names it
|
Antimicrob Agents Chemother |
1999 |
| Mycobacterium tuberculosis subsp. caprae subsp. nov.: a taxonomic study of a new member of the Mycobacterium tuberculosis complex isolated from goats in Spain.
doi:10.1099/00207713-49-3-1263
|
Int J Syst Bacteriol |
1999 |
| pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from northwestern Russia.
doi:10.1128/AAC.43.7.1764
names it
|
Antimicrob Agents Chemother |
1999 |
| Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA.
doi:10.1128/AAC.43.7.1761
names it
|
Antimicrob Agents Chemother |
1999 |
| [pncA gene mutations in clinical isolates of tubercle bacillus by polymerase chain reaction-direct sequencing method: in relationship to pyrazinamide resistance].
names it
|
Kekkaku |
1999 |
| Molecular markers demonstrate that the first described multidrug-resistant Mycobacterium bovis outbreak was due to Mycobacterium tuberculosis.
doi:10.1128/JCM.37.4.971-975.1999
|
J Clin Microbiol |
1999 |
| Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide.
doi:10.1128/AAC.43.3.537
|
Antimicrob Agents Chemother |
1999 |
| Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru.
doi:10.1054/tuld.1998.0013
|
Tuber Lung Dis |
1998 |
| Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.
doi:10.1054/tuld.1998.0002
|
Tuber Lung Dis |
1998 |
| Novel pncA Mutations in Pyrazinamide-Resistant Isolates of Mycobacterium tuberculosis.
doi:10.154/MODI00300229
names it
|
Mol Diagn |
1998 |
| [Mechanisms of drug-resistance in mycobacteria].
|
Nihon Rinsho |
1998 |
| [Multidrug-resistant tuberculosis. 2. Mechanisms of drug-resistance in Mycobacterium tuberculosis--genetic mechanisms of drug-resistance].
|
Kekkaku |
1998 |
| Purification, gene cloning, targeted knockout, overexpression, and biochemical characterization of the major pyrazinamidase from Mycobacterium smegmatis.
doi:10.1128/JB.180.22.5809-5814.1998
|
J Bacteriol |
1998 |
| Differentiation of BCG-induced lymphadenitis from tuberculosis in lymph node biopsy specimens by molecular analyses of pncA and oxyR.
doi:10.1002/(SICI)1096-9896(199801)184:1<96::AID-PATH989>3.0.CO;2-M
names it
|
J Pathol |
1998 |
| Allele-specific PCR method based on pncA and oxyR sequences for distinguishing Mycobacterium bovis from Mycobacterium tuberculosis: intraspecific M. bovis pncA sequence polymorphism.
doi:10.1128/JCM.36.1.239-242.1998
names it
|
J Clin Microbiol |
1998 |
| Absence of the genetic marker IS6110 from a strain of Mycobacterium tuberculosis isolated in Ontario.
doi:10.1155/1998/292491
|
Can J Infect Dis |
1998 |
| Molecular techniques in the diagnosis of drug-resistant tuberculosis.
|
Ann Acad Med Singap |
1997 |
| [Rapid diagnosis of tuberculosis].
|
Kekkaku |
1997 |
| The pncA gene from naturally pyrazinamide-resistant Mycobacterium avium encodes pyrazinamidase and confers pyrazinamide susceptibility to resistant M. tuberculosis complex organisms.
doi:10.1099/00221287-143-10-3367
names it
|
Microbiology (Reading) |
1997 |
| Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms.
doi:10.1128/AAC.41.3.636
names it
|
Antimicrob Agents Chemother |
1997 |
| Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis.
doi:10.1128/AAC.41.3.540
names it
|
Antimicrob Agents Chemother |
1997 |
| Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis.
doi:10.1016/s0962-8479(98)80004-x
names it
|
Tuber Lung Dis |
1997 |
| Rapid differentiation of bovine and human tubercle bacilli based on a characteristic mutation in the bovine pyrazinamidase gene.
doi:10.1128/jcm.35.1.106-110.1997
|
J Clin Microbiol |
1997 |
| Identification, cloning, and expression of the Escherichia coli pyrazinamidase and nicotinamidase gene, pncA.
doi:10.1128/AAC.40.6.1426
names it
|
Antimicrob Agents Chemother |
1996 |
| Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus.
doi:10.1038/nm0696-662
names it
|
Nat Med |
1996 |